RNA targeting unleashes indiscriminate nuclease activity of CRISPR-Cas12a2

Nature. 2023 Jan;613(7944):582-587. doi: 10.1038/s41586-022-05560-w. Epub 2023 Jan 4.

Abstract

Cas12a2 is a CRISPR-associated nuclease that performs RNA-guided, sequence-nonspecific degradation of single-stranded RNA, single-stranded DNA and double-stranded DNA following recognition of a complementary RNA target, culminating in abortive infection1. Here we report structures of Cas12a2 in binary, ternary and quaternary complexes to reveal a complete activation pathway. Our structures reveal that Cas12a2 is autoinhibited until binding a cognate RNA target, which exposes the RuvC active site within a large, positively charged cleft. Double-stranded DNA substrates are captured through duplex distortion and local melting, stabilized by pairs of 'aromatic clamp' residues that are crucial for double-stranded DNA degradation and in vivo immune system function. Our work provides a structural basis for this mechanism of abortive infection to achieve population-level immunity, which can be leveraged to create rational mutants that degrade a spectrum of collateral substrates.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • CRISPR-Associated Proteins* / antagonists & inhibitors
  • CRISPR-Associated Proteins* / metabolism
  • CRISPR-Cas Systems*
  • Catalytic Domain
  • DNA / chemistry
  • DNA / immunology
  • DNA / metabolism
  • Enzyme Activation
  • RNA* / chemistry
  • RNA* / metabolism
  • Substrate Specificity

Substances

  • CRISPR-Associated Proteins
  • DNA
  • RNA
  • Cas12a protein